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Editors: Anton N. Sidawy and Bruce A. PerlerCarbon dioxide digital subtraction angiography as an
option for detection of endoleaks in endovascular
abdominal aortic aneurysm repair procedure
Eijun Sueyoshi, MD, Hiroki Nagayama, MD, Ichiro Sakamoto,
MD, Masataka Uetani, MD
Objective: The purpose of this study was to evaluate carbon
dioxide digital subtraction angiography (CO2-DSA) as an
option for the detection of endoleaks (ELs) in the endo-
vascular abdominal aortic aneurysm repair (EVAR)
procedure.
Methods: Forty patients with abdominal aortic aneurysm
who were scheduled to undergo EVAR were enrolled in the
study. There were 35 men and ﬁve women (mean age, 77.9
years). All patients had both iodinated contrast conven-
tional DSA (C-DSA) and CO2-DSA immediately after EVAR.
The sensitivity and speciﬁcity were calculated for the ability
of CO2-DSA to detect ELs. We also correlated with com-
puted tomography ﬁndings 6 months after EVAR.
Results: C-DSA showed that 27 of the 40 patients (68%) had
28 ELs (type I, four; type II, 20; type III, three; type IV, one).
CO2-DSA showed that 16 of the 40 patients (40%) had 17
ELs (type I, four; type II, 10; type III, three; type IV, none).
For the prediction of direct ELs (type I and type III) with use
of C-DSA as the criterion standard, CO2-DSA has a sensitivity
of 1.0 and a speciﬁcity of 1.0. For the detection of persistent
type II ELs (n = 11) with use of computed tomography
ﬁndings 6 months from EVAR as the criterion standard, CO2-
DSA has a sensitivity of 0.87 and a speciﬁcity of 0.97. C-DSA
has a sensitivity of 0.82 and a speciﬁcity of 0.64.
Conclusions: CO2-DSA is reliable for the detection of direct
ELs and persistent type II ELs in EVAR. CO2-DSA can be an
option to detect ELs in the EVAR procedure.Endovascular balloon occlusion is associated with reduced
intraoperative mortality of unstable patients with
ruptured abdominal aortic aneurysm but fails to improve
other outcomes
Maxime Raux, MD, Jean Marzelle, MD, Hicham Kobeiter,
MD, PhD, Gilles Dhonneur, MD, Eric Allaire, MD, PhD,
Frédéric Cochennec, MD, Jean-Pierre Becquemin, MD, PhD,
Pascal Desgranges, MD, PhD
Background: Proximal aortic control by endovascular bal-
loon occlusion (EBO) is an alternative to conventional aortic*Full articles available online at www.jvascsurg.org
1078-5884/$ e see front matter
http://dx.doi.org/10.1016/S1078-5884(15)00034-9cross-clamping (CAC) in hemodynamically unstable patients
presenting with a ruptured abdominal aortic aneurysm
(rAAA). The aim of this study was to evaluate the potential
clinical beneﬁt of EBO over CAC.
Methods: Data from 72 patients with rAAA treated at our
institution from 2001 to 2013 were retrospectively ana-
lyzed. All patients were hemodynamically unstable (mean
arterial blood pressure at admission <65 mm Hg or asso-
ciated unconsciousness, cardiac arrest, or emergency
endotracheal intubation). Clinical end points of hemody-
namic restoration, mortality rate, and major postoperative
complications were assessed for CAC (group 1) and EBO
(group 2).
Results: At admission, 72 patients were unstable. CAC was
performed in 40 and EBO in 32. Intraoperative mortality
was 43% in group 1 vs 19% in group 2 (P = .031). In group 1,
the approach for CAC (thoracotomy [n = 23] vs laparotomy
[n = 17]) did not inﬂuence intraoperative mortality (43% vs
41%). There was no signiﬁcant difference in 30-day (75% vs
62%) and in-hospital (77% vs 69%) mortality rates between
groups. After EBO, the treatmentdopen vs endovascular
repairddid not inﬂuence the intraoperative mortality rate
(31% vs 43%; P = .5). Eight surgical complications were
secondary to CAC (1 vena cava injury, 3 left renal vein
injuries, 1 left renal artery injury, 1 pancreaticoduodenal
vein injury, and 2 splenectomies), but no EBO-related
complication was noted (P = .04). Differences in colon
ischemia (15% vs 28%) and renal failure (12% vs 9%) were
not statistically signiﬁcant. Abdominal compartment syn-
drome occurred in four patients in group 2 and in no
patients in group 1.
Conclusions: Compared with CAC, EBO is a feasible and
valuable strategy and is associated with reduced intra-
operative mortality of unstable rAAA patients, but not in-
hospital mortality, in this retrospective study.Three-dimensional fusion computed tomography
decreases radiation exposure, procedure time, and
contrast use during fenestrated endovascular aortic repair
Michael M. McNally, MD, Salvatore T. Scali, MD, Robert J.
Feezor, MD, Daniel Neal, MS, Thomas S. Huber, MD, PhD,
Adam W. Beck, MD
Objective: Endovascular surgery has revolutionized the
treatment of aortic aneurysms; however, these improve-
ments have come at the cost of increased radiation and
contrast exposure, particularly formore complex procedures.
Three-dimensional (3D) fusion computed tomography (CT)
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The purpose of this analysis was to determine the effect of
using intraoperative 3D fusion CT on the performance of
fenestrated endovascular aortic repair (FEVAR).
Methods: Our institutional database was reviewed to
identify patients undergoing branched or FEVAR. Patients
treated using 3D fusion CT were compared with patients
treated in the immediate 12-month period before imple-
mentation of this technology when procedures were per-
formed in a standard hybrid operating room without CT
fusion capabilities. Primary end points included patient
radiation exposure (cumulated air kerma: mGy), ﬂuoroscopy
time (minutes), contrast usage (mL), and procedure time
(minutes). Patients were grouped by the number of aortic
graft fenestrations revascularized with a stent graft, and
operative outcomes were compared.
Results: A total of 72 patients (41 before vs 31 after 3D
fusion CT implementation) underwent FEVAR from Sep-
tember 2012 through March 2014. For two-vessel fenes-
trated endografts, there was a signiﬁcant decrease in
radiation exposure (3400  1900 vs 1380  520 mGy; P =
.001), ﬂuoroscopy time (63  29 vs 41  11 minutes; P =
.02), and contrast usage (69  16 vs 26  8 mL; P = .0002)
with intraoperative 3D fusion CT. Similarly, for combined
three-vessel and four-vessel FEVAR, signiﬁcantly decreased
radiation exposure (5400  2225 vs 2700  1400 mGy; P <
.0001), ﬂuoroscopy time (89  36 vs 64  21 minutes; P =
.02), contrast usage (90  25 vs 39  17 mL; P < .0001),
and procedure time (330  100 vs 230  50 minutes; P =
.002) was noted. Estimated blood loss was signiﬁcantly less
(P < .0001), and length of stay had a trend (P = .07) toward
being lower for all patients in the 3D fusion CT group.
Conclusions: These results demonstrate that use of intra-
operative 3D fusion CT imaging during FEVAR can sig-
niﬁcantly decrease radiation exposure, procedure time, and
contrast usage, which may also decrease the overall phys-
iologic impact of the repair.Staged endovascular repair of thoracoabdominal aortic
aneurysms limits incidence and severity of spinal cord
ischemia
Adrian O’Callaghan, MD, Tara M. Mastracci, MD, Matthew J.
Eagleton, MD
Objective: Neurologic dysfunction remains a persistent
complication of extensive aortic repair owing to disruption
of the spinal collateral network. We hypothesized that
staged repair might mitigate the incidence and severity of
this spinal cord ischemia (SCI).
Methods: We conducted a retrospective cohort study of
patients undergoing a Crawford type II repair of a thor-
acoabdominal aortic aneurysm between January 2008 and
July 2013. Baseline demographics, incidence of prior aortic
surgery, comorbidities, and outcomes were prospectively
recorded. Staged repair was deﬁned as intentional com-
pletion of the endovascular repair as two temporally sep-
arate procedures, referred to as a two-stage repair. Extentof aortic cover was calculated by three-dimensional imaging
and reported as the proportion of the aorta covered
between the left subclavian artery and the aortic bifurca-
tion. Primary outcome measures were incidence and
severity of SCI and mortality.
Results: The study included 87 patients, divided into the
following subgroups: single-stage repair (n = 32; repair in a
single procedure, without prior aortic surgery), two-stage
repair (n = 27; repair in two separate procedures, without
prior aortic surgery), and unintentionally staged repair (n =
28; those with prior aortic surgery, without an intention to
stage). Median time between stages was 5 months (range, 1-
60 months). All groups were equivalent in terms of demo-
graphics and risk factors; however, the staged group had
signiﬁcantly greater proximal aortic cover (P = .001). The
overall rates of SCI in the nonstaged and staged groups were
37.5% (12 of 32) and 11.1% (3 of 27), respectively (P = .03).
Furthermore, all neurologic injuries in the staged group were
temporary.The 30-day survival in the single-stage, two-stage,
and unintentionally staged repairs was 18.8%, 0%, and
10.7%, respectively (P = .52).
Conclusions: Staged repair appears both to protect against
SCI and to enhance overall survival in extensive aortic repair.Identiﬁcation of a potential proinﬂammatory genetic
proﬁle inﬂuencing carotid plaque vulnerability
Federico Biscetti, MD, PhD, Giuseppe Straface, MD,
Giovanni Bertoletti, MD, Claudio Vincenzoni, MD, Francesco
Snider, MD, Vincenzo Arena, MD, Raffaele Landolﬁ, MD,
Andrea Flex, MD
Objective: Atherosclerosis and vascular remodeling after
injury are driven by inﬂammation and mononuclear cell
inﬁltration. Unstable atherosclerotic plaques are charac-
terized by a large necrotic core. In this study we inves-
tigated the distribution and interaction between gene
polymorphisms encoding proinﬂammatory molecules in an
Italian population with internal carotid artery stenosis
(ICAS). We also evaluated whether reciprocal interaction
between these gene polymorphisms increased the risk of
plaque vulnerability.
Methods: In this genetic association study, 11 proin-
ﬂammatory gene polymorphisms were analyzed in 933
individuals comprising 344 patients with ICAS who under-
went carotid endarterectomy and 589 controls without
ultrasound evidence of atherosclerosis or intimal
thickening.
Results: We found that interleukin (IL) 6 (IL-6), IL-1b,
monocyte chemoattractant protein-1 (CCL2) macrophage
inﬂammatory protein-1a (CCL3), E-selectin (SELE), inter-
cellular adhesion molecule 1 (ICAM1), and matrix metal-
loproteinase-3 (MMP-3), and 9 (MMP-9) gene variants were
independently and signiﬁcantly associated with ICAS. The
association remained signiﬁcant even after the Bonferroni
correction. We also found a genetic proﬁle associated with
different risks for ICAS, depending on the number of high-
risk genotypes simultaneously present in an individual.
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niﬁcantly more common in individuals with unstable carotid
plaque.
Conclusions: Our study shows, for the ﬁrst time, a reciprocal
interaction between proinﬂammatory genotypes for the
development and progression of ICAS.Drug-eluting balloons for femoropopliteal lesions show
better performance in de novo stenosis or occlusion than
in restenosis
Monika Herten, PhD, Giovanni B. Torsello, PhD, Eva
Schönefeld, MD, Britta Imm, Nani Osada, PhD, Stefan
Stahlhoff, MD
Objective: Although drug-eluting balloons (DEBs) have
shown promising results treating de novo (DN) athero-
sclerotic lesions and appear to have been widely adopted in
Europe, their long-term efﬁcacy in the broad spectrum of
femoropopliteal restenosis (RE) remains to be proven. The
purpose of the study was to assess the efﬁcacy of paclitaxel-
DEBs in restenotic (stented and nonstented) vs DN stenotic
femoropopliteal arteries.
Methods: The study prospectively enrolled 100 patients
undergoing femoropopliteal endovascular intervention by
DEB for RE or DN stenosis. Patients who received additive
atherectomy were excluded. The primary end point was the
primary patency (PP) rate at 12 months. Secondary end
points were sustained clinical improvement and clinically
driven target lesion revascularization.
Results: DEBs were used to treat 105 limbs for intermittent
claudication (82 [78%]) or critical limb ischemia (23 [22%])
in 100 patients. Of these, 111 lesions were DN stenosis (46
[41%]) or RE (65 [59%]). The overall PP was 86% at 6 months
and 74% at 12 months. PP of DN stenosis was higher at 6
months (93% vs 81%) and was signiﬁcantly (P = .021) better
than RE at 12 months (85% vs 68%). Sustained clinical
improvement based on Rutherford classiﬁcation was sig-
niﬁcant in both groups (P < .001). Target lesion revascula-
rization was signiﬁcantly lower in DN stenosis compared
with RE at 12 months (15% vs 32%; P = .021).
Conclusions: DEB angioplasty is an effective therapy for DN
femoropopliteal lesions. The results of DEB angioplasty for
RE are inferior compared with DN stenosis after 12 months.
Nevertheless, results of DEB angioplasty for RE seem com-
parable with technically more demanding literature-derived
strategies.Clinical outcome after infrapopliteal bypass surgery in
chronic hemodialysis patients with critical limb ischemia
Yoshitaka Kumada, MD, PhD, Haruhiko Nogaki, MD, PhD,
Hideki Ishii, MD, PhD, Toru Aoyama, MD, PhD, Daisuke
Kamoi, MD, PhD, Hiroshi Takahashi, BSc, Toyoaki Murohara,
MD, PhD
Objective: Lower extremity bypass surgery has been widely
performed to treat critical limb ischemia (CLI) in patients onhemodialysis (HD). However, the clinical outcome still
remains unclear. We investigated the limb salvage rate after
infrapopliteal bypass surgery in HD patients with CLI.
Methods: From April 2006 to January 2013, 226 patients
with 236 limbs who electively underwent bypass surgery for
treatment of CLI due to infrapopliteal disease were enrol-
led. Patients were grouped by those who were on HD (n =
177) and those who were not (n = 49). They were moni-
tored for 5 years or until December 2013 if the follow-up
period was <5 years. Amputation-free survival, deﬁned as
freedom from major amputation or all-cause death, was
primarily evaluated. Incidence of reintervention was also
analyzed.
Results: Ulcer/gangrene was present in 206 patients
(91.2%), and 233 limbs (98.7%) were treated using autog-
enous vein. Age was younger (67  9 vs 72  9 years; P =
.0011) and ulcer/gangrene was more prevalent (93.8% vs
81.6%, P = .0080) in HD patients than in non-HD patients.
During the follow-up period (median, 28 months), 33
(14.6%) major amputations and 28 reinterventions (12.4%)
occurred, and 65 patients (28.8%) died. The 5-year ampu-
tation-free survival rate was signiﬁcantly lower in HD
patients than in non-HD patients (43.6% vs 78.8%, P =
.0033), and the adjusted hazard ratio (HR) for amputation or
death for HD patients was 2.36 (95% conﬁdence interval
[CI], 1.13-4.92; P = .022). Compared with non-HD patients,
the status of HD was similarly an independent risk of major
amputation (72.4% vs 92.5%; adjusted HR, 4.36; 95% CI,
1.04-18.3; P = .045) and mortality (56.9% vs 83.2%; adjusted
HR, 2.81; 95% CI, 1.30-6.09; P = .0085). However, freedom
from reintervention was comparable between the two
groups (84.3% vs 86.8%; P = .89). In HD patients, body
mass index (HR, 0.86; 95% CI, 0.76-0.96; per 1 kg/m2
increase; P = .014) and C-reactive protein (HR, 1.06; 95% CI,
1.01-1.11; P = .014) independently predicted major ampu-
tation. Elevated C-reactive protein levels were also asso-
ciated with death (HR, 1.04; 95% CI, 1.01-1.09; P = .047).
Conclusions: The clinical outcome after infrapopliteal
bypass surgery was poorer in HD patients with CLI com-
pared with non-HD patients. Malnutrition or chronic
inﬂammation was associated with poor outcome in HD
patients with CLI due to infrapopliteal occlusive disease.Mortality beneﬁts of different hemodialysis access types
are age dependent
Caitlin W. Hicks, MD, MS, Joseph K. Canner, MHS, Isibor
Arhuidese, MD, MPH, Devin S. Zarkowsky, MD, Umair Qazi,
MD, MPH, Thomas Reifsnyder, MD, James H. Black III, MD,
Mahmoud B. Malas, MD, MHS
Objective: Risk of death in dialysis patients is lowest with
arteriovenous ﬁstulas (AVFs), followed by arteriovenous
grafts (AVGs) and then intravenous hemodialysis catheters
(HCs). Our aim was to analyze the effects of age at hemo-
dialysis initiation on mortality across different access types.
Methods: All patients 18 years in the United States Renal
Data System between the years 2006 and 2010 were
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tional hazard models were used to analyze the effect of age
on mortality for ﬁrst dialysis access with AVF vs AVG vs HC.
Results: The study analyzed 507,791 patients (63.4  0.02
years; 56.5% male; 40.9% mortality; follow-up, 1.57  1.36
years). Increasing age was a signiﬁcant predictor of overall
mortality (adjusted hazard ratio [aHR], 1.03; P < .001).
Compared with patients with HCs (n = 418,932), overall risk-
adjusted mortality was lowest in patients with AVFs (n =
71,316; aHR, 0.63; P < .001) followed by AVGs (n = 17,543;
aHR, 0.83; P < .001). AVF was superior to both HC and AVG
for all age groups (P < .001). However, there was a sig-
niﬁcant change in the relative efﬁcacy of AVG at ages 48years and 89 years based on spline modeling; there were no
signiﬁcant differences comparing adjusted mortality with
AVG vs HC for patients aged 18 to 48 years or for patients
>89 years, but AVG was superior to HC for patients 49 to 89
years of age (aHR, 0.811; P < .001). The mortality beneﬁt of
AVF was consistently superior to that of AVG and HC for
patients of all ages (all, P < .001).
Conclusions: AVF is superior to AVG and HC regardless of
the patient’s age, including in octogenarians. In contrast,
the mortality beneﬁt of AVG over HC may not apply to
younger (18-48 years) or older (>89 years) age groups. All
patients 18 to 48 years should receive AVF for dialysis
access whenever possible.
